Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Urch Publishing Reports | Cancer Market Trends 2008 - 2012

Cancer Market Trends 2008 - 2012

Updated, comprehensive report delivers accurate market figures and forecasts on the global cancer drug market. Contains profiles of top pharmaceutical companies in this sector.

"The global market for new cancer patients is set to increase from 4.0 million cases in the major cancer markets in 2007 to 4.2 million in 2012"

The global cancer market has seen a continued period of rapid growth. Global sales for cancer-treating drugs increased by 13.3% in 2007, primarily driven by growth in sales of innovative drugs. Although growth rates for this market will slow due to generic competition, the market is predicted to expand to $103.9 billion by 2012, equivalent to CAGR of 9.4%.

Key findings from this report:

* The global cancer market grew to US$66.2 billion in 2007, a year-on-year increase of 13.3%.

* This market growth in 2007 was primarily driven by growth of 44.0% in innovatives sales.

* There were a total of 21 different cancer therapies generating global sales in excess of US$1 billion in 2007.

* The leading company by cancer sales in 2007 was Amgen, with sales of US$11.1 billion.

* The global cancer market is forecast to expand to US$103.9 billion in 2012, equivalent to a CAGR of 9.4% over the next 5 years.

This comprehensive report delivers market forecasts and overviews to help inform your pharmaceutical business decision-making.

Features of the report:

* Sales forecast for top ten companies providing cancer treatment medicines.

* Analysis of leading cancer products likely to loose patent protection in the next ten years.

* Sales forecasts to 2012 for the top ten cancer medicines and forecasts by drug class.

* Overview of disease incidence, areas of growth and breakdown of disease burden and mortality.

* Breakdown of the major market trends and business opportunities

Use This Report To:

* Benchmark your company's portfolio against market trends and forecasts to plan better for greater profitability.

* Identify potential areas of pharmaceutical market growth and opportunities for delivering successful sales growth

* Support your internal planning processes by using an external perspective founded on detailed analysis and transparent market forecasts.

The 122 page publication contains 49 Figures and 43 Tables to help you make sense of the wealth of data. This unique report from URCH Publishing will be of particular use to those involved in:

- corporate planning,

- sales and marketing,

- portfolio management, and,

- market forecasting.

Cancer Market Trends 2008 - 2012 is divided into five key sections. Chapters 2-5 present historical trends for key disease markets, key drug classes, key products and key companies. The final report chapter outlines future cancer market trends and major growth opportunities. The data and analysis contained within the report are comprehensive, consistent and up-to-date and thus provide a single-point of reference for understanding cancer market trends.

Publication Date January 2009

ISBN 9781905751020

Pages 122

Tables 46

Figures 49

Single User - PDF
Table of Contents
Price: $1,695.00 / €1,132.94

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions